VINCENT MULLER: Open Payments
NPI 1053412692 · SOCORRO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 19 payments from 11 companies in 2025. Trend: 2023 $721 · 2024 $591 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Novo Nordisk Inc | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, XIFAXAN, ZENPEP, Rybelsus, PAXLOVID, BREZTRI, Kerendia, CAPLYTA.
Industry payments across NM — which companies pay providers there.
